Envoy Medical, Inc. COCH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -37.49% | 33.94% | -1.60% | -13.92% | -13.85% |
| Total Depreciation and Amortization | 1.37% | -8.75% | 5.26% | -10.59% | 39.34% |
| Total Amortization of Deferred Charges | 3.96% | 0.44% | -7.76% | -0.41% | -0.40% |
| Total Other Non-Cash Items | 171.49% | -342.17% | -51.59% | 29.93% | 1,811.63% |
| Change in Net Operating Assets | 10.42% | -1,071.79% | -89.76% | 889.61% | -91.65% |
| Cash from Operations | 9.98% | -6.61% | -31.26% | 2.89% | -19.73% |
| Capital Expenditure | -- | -- | -- | 100.00% | 83.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | 83.33% |
| Total Debt Issued | -- | -- | -- | -100.00% | 0.00% |
| Total Debt Repaid | -2.40% | -8.90% | 28.46% | -13.14% | -1.29% |
| Issuance of Common Stock | -99.65% | 630.39% | 51.55% | 864.41% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 100.00% | 49.96% |
| Other Financing Activities | 100.00% | -204.33% | 1,243.67% | -- | -- |
| Cash from Financing | -100.40% | 356.52% | 132.22% | -41.39% | 24.87% |
| Foreign Exchange rate Adjustments | 0.00% | -- | 100.00% | 50.00% | -133.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.90% | 11,655.19% | 110.57% | -6,824.00% | 85.38% |